Exelixis
The Senior DMPK Director at Exelixis is responsible for developing and implementing DMPK strategies to advance drug candidates from the discovery to development stage and build comprehensive DMPK packages for successful drug registration. This position involves providing strategic expertise and scientific oversight for various programs while contributing to departmental growth and potentially mentoring junior scientists.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Executive Director, DMPK - Respiratory and Immunology
AstraZeneca
Drug Metabolism and Pharmacokinetics (DMPK) Lead/Director
UCB
Senior Director/Executive Director, DMPK
Iambic Therapeutics
DMPK Team Lead
Denali Therapeutics
Associate Director, Discovery DMPK – In Vitro ADME
pharmaron
Director of DMPK
wattonhall